Historical cboe News Stories
Cboe Q1 Gains, Cuts Staff, Sells Canada/Australia!
Cboe reported robust Q1 results with roughly 29% revenue growth and a high ROIC, announced a ~20% workforce reduction and plans to divest Canadian and Australian units. The stock jumped about 10% as the company refocused on core U.S. businesses and rolled out operational and regulatory enhancements including appointed market makers, odd-lot handling updates, and new indices.
CBOE Stock: Q1 Beats, Revenue & EPS Surge
Cboe delivered a stronger-than-expected Q1 2026: net revenue rose ~29% to $728.9M and diluted EPS jumped to $3.66. Broad strength across options, cash/spot, Data Vantage and FX, plus lowered expense guidance and planned divestitures, lifted the stock and prompted an upgraded full-year outlook.
CBOE Stock Sees Insider Sales Ahead of Q1 Earnings
Cboe Global Markets (CBOE) experienced increased insider selling this week while equity indices rallied. With Q1 earnings due May 1 and consensus EPS near $2.94, investors are focused on whether elevated options volumes—especially 0DTE activity—will sustain revenue growth after a strong Q4.
Cboe Volume Surge, SPX AM/PM Filing Ahead: Outlook
Cboe reported a record single-day proprietary index options volume on April 14, 2026, driven by heavy SPX and VIX activity. A new rule filing (SR‑CBOE‑2026‑037) seeks to add SPX AM/PM basis options, and Cboe’s Q1 2026 results due May 1 will be the next near-term catalyst for the stock.
Cboe Gains Spotlight: CNBC & Near‑24×5 Trading
Cboe announced CNBC will broadcast daily from its Chicago trading floor and filed to launch near‑24×5 equities trading on EDGX. Strong Q4 2025 results and margin gains underpin the exchange’s push into extended hours and data-led growth.
CBOE Stock: VIX Surge Sparks Derivatives Rally Now
Cboe's shares are benefiting from a recent surge in volatility: VIX spikes and elevated correlation are driving higher derivatives activity while record Q4 2025 results and a new event‑prediction product give the exchange added growth levers. Short‑term upside depends on sustained trading volumes and product adoption.
Cboe Unveils Three Outcome SPX Prediction Contract
Cboe launched a three-outcome SPX prediction contract allowing partial payouts for near-miss outcomes. The move, announced March 9, 2026, could broaden derivatives demand, diversify fees, and act as a near-term catalyst for CBOE shares—subject to adoption, liquidity, and regulatory review.
Cboe Tops 52W High After Q4 Beat; 24×5 RUT Rise Up
Cboe surged after a strong Q4 report and product expansions. Record revenue and EPS, a push into near-24×5 Russell 2000 options, renewed interest in binary-style contracts, and European leadership shifts drove a sustained rally and heavier trading volumes.
CBOE Stock Soars on Q4 Beat; 0DTE Options Surge Up
Cboe Global Markets’ strong Q4 and full-year 2025 results, driven by a surge in options trading—particularly zero-days-to-expiration (0DTE) activity—lifted the stock to a 52-week high. Revenue and adjusted EPS topped expectations, derivatives revenue climbed sharply, and management issued mid-single-digit organic growth guidance for 2026. Strategic moves including extended Russell 2000 options hours and a tightened geographic focus reinforce a derivatives-first thesis for investors.
Cboe Surges: Q4 Earnings, 0DTE Boom & Binary Rise!
Cboe reported a blockbuster Q4 with record revenue and EPS, driven by a surge in 0DTE options and derivatives activity. Strategic product moves—reviving binary-style contracts and pushing retail on-exchange trading in Europe—plus strong capital returns, position CBOE for continued upside while regulatory and structural shifts remain key catalysts.